About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD., First Half Ordinary Profit Decreases by 51%, July-September Ordinary Profit Decreases by 21%

Wed Nov 6, 2024 11:30 am JST Earnings

2395 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 【J-GAAP】

Earnings Report

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. <2395> [TSE-P] announced its financial results at noon (11:30) on November 6th. The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) significantly dropped by 51.3% from the same period last year to 1.82 billion yen. The progress rate against the 5.34 billion yen full-year plan was 34.2%, also falling below the five-year average of 46.0%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow by 7.9% from the same period last year, reaching 3.51 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit decreased to 1.48 billion yen, a 20.9% decrease compared to the same period last year. The operating profit margin sharply declined from 18.5% in the same period last year to 3.2%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 10,348 2,313 5,928 4,419 106.2 64.5 Oct 31, 2022 J-GAAP
Apr - Sep, 2023 11,884 2,349 3,756 2,966 71.2 53.5 Nov 7, 2023 J-GAAP
Apr - Sep, 2024 12,508 80 1,829 1,331 32.0 34.2 Nov 6, 2024 J-GAAP
YoY +5.3% -96.6% -51.3% -55.1% -55.1%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 12,002 -202 1,332 858 20.6 20 May 8, 2024 J-GAAP
Apr - Sep, 2024 Results 12,508 80 1,829 1,331 32.0 20 Nov 6, 2024 J-GAAP
Revision Rate +4.2% － +37.3% +55.1% +55.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 14,566 1,813 3,259 2,565 61.6 30 May 8, 2024 J-GAAP
Oct - Mar, 2024 Guidance 17,327 2,270 3,516 2,589 62.2 30 Nov 6, 2024 J-GAAP
YoY +19.0% +25.2% +7.9% +0.9% +0.9%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 25,090 5,245 9,194 6,060 145.6 50 May 8, 2023 J-GAAP
Mar, 2024 26,450 4,162 7,015 5,531 132.9 50 May 8, 2024 J-GAAP
Mar, 2025 Guidance 29,835 2,350 5,345 3,920 94.2 50 May 8, 2024 J-GAAP
YoY +12.8% -43.5% -23.8% -29.1% -29.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 6,080 1,122 1,879 1,593 38.3 18.5 Nov 7, 2023 J-GAAP
Oct - Dec, 2023 6,100 186 1,128 828 19.9 3.0 Feb 2, 2024 J-GAAP
Jan - Mar, 2024 8,466 1,627 2,131 1,737 41.7 19.2 May 8, 2024 J-GAAP
Apr - Jun, 2024 5,549 -145 342 122 2.9 -2.6 Aug 6, 2024 J-GAAP
Jul - Sep, 2024 6,959 225 1,487 1,209 29.0 3.2 Nov 6, 2024 J-GAAP
YoY +14.5% -79.9% -20.9% -24.1% -24.1%

Related Articles